Equillium to present at the jonestrading 2023 healthcare summit

La jolla, calif.--(business wire)---- $eq--equillium, inc. (nasdaq: eq), a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the jonestrading 2023 healthcare summit taking place october 9 - 11 at the eden roc hotel in miami, florida. in addition to one-on-one investor meetings, management will participate in a panel presentation focused on industry trends that influence drug discov.
EQ Ratings Summary
EQ Quant Ranking